TV: SHELLER ON PHARMA & COURTS
Stephen Sheller appeared on the Philadelphia CNN-News affiliate WFMZ-TV program The American Law Journal on “How Is Pharma Faring in the Courts?” Host Christopher Naughton welcomed plaintiff’s attorneys Christopher Placitella, Esq. of Cohen Placitella & Roth, Stephen Sheller of Sheller, P.C., corporate defense counsel Terry Henry of Blank Rome and Bloomberg News Reporter Jef Feeley. In an opening feature report, […]
#1 PA V&S 2013-2014
Sheller, P.C. had the largest settlement in Pennsylvania in 2013-2014 as published in American Lawyer Media’s Legal Intelligencer newspaper. The $2.2 billion settlement with Janssen Pharmaceuticals, a division of Johnson & Johnson, was a qui tam case where Sheller, P.C. represented the whistleblower who brought the qui tam charges. With the U.S. Department of Justice, […]
In The Philadelphia Inquirer: Sheller $2.2 Billion J&J Pharma Settlement
J&J to pay $2.2B for Improper Promotion of Risperdal BY DAVID SELL WASHINGTON – Health-care giant Johnson & Johnson agreed Monday to plead guilty to a criminal misdemeanor charge and pay $2.2 billion to settle allegations that it illegally promoted the use of its antipsychotic drugs for unapproved uses, including for children and the elderly. […]
J&J Loses Trial Over Risperdal and Male Breast
The Wall Street Journal Pharmalot Blog 2015-02-24 In a setback to Johnson & Johnson, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males. The lawsuit was brought by the family of […]
Legal Intelligencer Quotes Sheller on Risperdal Suit Filings
The Legal Intelligencer 2014-01-15 Individual suit filings related to the antipsychotic drug Risperdal have been increasing in the Philadelphia Court of Common Pleas, First Judicial District leaders say. The uptick has been steady since actions against Johnson & Johnson and its subsidiaries began four years ago, according to the court officials. “We have a group […]
$2.2B Settlement “Leads the Pack”
The $2.2 Billion Settlement with Johnson & Johnson Leads the Pack by Lizzy McLellan, The Legal Intelligencer The Legal Intelligencer reported that the largest verdict and settlement award in Pennsylvania between August 2013 and August 2014 was handled by Sheller, P.C. with a $2.2 billion settlement over healthcare giant Johnson & Johnson and its subsidiary, […]
Sheller Quoted in “Dangers of Off-Label Drug Use Kept Secret”
The Toronto Star 2014-06-26 By: David Bruser News Reporter, Jesse McLean Investigative News reporter, Andrew Bailey Data Analyst, Published on Thu Jun 26 2014 A 15-year-old girl who wanted to clear her acne was prescribed the antibiotic minocycline. The teen developed lupus-like symptoms — her immune system attacked her own tissues and organs — and she died. The drug was not approved […]
Legal Intelligencer Quotes Sheller on Low T Drug Cases
Law.com 2014-03-04 Several products liability attorneys say that the recent appearance of lawsuits nationwide against the manufacturers of testosterone therapy drugs indicates the potential for multidistrict litigation and possibly a new mass tort. Many of the current suits filed in federal courts across the country are against Abbott Laboratories—maker of the topical testosterone therapy drug […]
Sheller in Bloomberg Business on Whistleblowers and J&J $2.2B Settlement
Bloomberg Business Week 2013-12-09 Judy Doetterl was a sales representative for Johnson & Johnson (JNJ) in 2004 when federal agents placed a hidden recording device on her and sent her to tape marketing presentations at a national company sales meeting. U.S. prosecutors wanted to prove claims by Doetterl and others that J&J boosted sales by urging doctors to prescribe […]
J&J to Pay at Least $2.5 Billion to Settle Hip Lawsuits
The Wall Street Journal 2013-11-19 The Wall Street Journal reports that Johnson & Johnson has agreed to pay at least $2.5 billion to settle nearly 8,000 hip implant lawsuits In its latest multibillion-dollar legal settlement, Johnson & Johnson has agreed to pay at least $2.5 billion to resolve thousands of lawsuits filed by patients who […]
